이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Integral Diagnostics 과거 수익 실적
과거 기준 확인 0/6
Integral Diagnostics의 수입은 연평균 -24.6%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 1.5%의 비율로 증가했습니다. 매출은 연평균 14.9%의 비율로 증가해 왔습니다.
주요 정보
-24.6%
수익 성장률
-28.4%
EPS 성장률
Healthcare 산업 성장 | 2.4% |
매출 성장률 | 14.9% |
자기자본 수익률 | -19.3% |
순이익 | -12.7% |
다음 실적 업데이트 | 27 Aug 2024 |
최근 과거 실적 업데이트
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Sep 11Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?
Sep 03수익 및 비용 분석
수익 및 비용 분석
Integral Diagnostics 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
31 Dec 23 | 456 | -58 | 26 | 0 |
30 Sep 23 | 449 | -16 | 26 | 0 |
30 Jun 23 | 441 | 25 | 25 | 0 |
31 Mar 23 | 418 | 23 | 24 | 0 |
31 Dec 22 | 395 | 21 | 22 | 0 |
30 Sep 22 | 378 | 18 | 21 | 0 |
30 Jun 22 | 361 | 15 | 21 | 0 |
31 Mar 22 | 361 | 18 | 21 | 0 |
31 Dec 21 | 360 | 22 | 22 | 0 |
30 Sep 21 | 356 | 26 | 22 | 0 |
30 Jun 21 | 351 | 31 | 22 | 0 |
31 Mar 21 | 333 | 32 | 21 | 0 |
31 Dec 20 | 315 | 32 | 19 | 0 |
30 Sep 20 | 295 | 28 | 18 | 0 |
30 Jun 20 | 276 | 23 | 16 | 0 |
31 Mar 20 | 263 | 22 | 18 | 0 |
31 Dec 19 | 250 | 21 | 19 | 0 |
30 Sep 19 | 241 | 21 | 21 | 0 |
30 Jun 19 | 232 | 21 | 24 | 0 |
31 Mar 19 | 222 | 19 | 23 | 0 |
31 Dec 18 | 211 | 17 | 23 | 0 |
30 Sep 18 | 200 | 16 | 22 | 0 |
30 Jun 18 | 189 | 15 | 21 | 0 |
31 Mar 18 | 187 | 15 | 21 | 0 |
31 Dec 17 | 185 | 15 | 20 | 0 |
30 Sep 17 | 182 | 15 | 20 | 0 |
30 Jun 17 | 180 | 15 | 20 | 0 |
31 Mar 17 | 177 | 16 | 19 | 0 |
31 Dec 16 | 175 | 16 | 19 | 0 |
30 Sep 16 | 171 | 14 | 18 | 0 |
30 Jun 16 | 168 | 11 | 18 | 0 |
31 Mar 16 | 165 | 11 | 17 | 0 |
31 Dec 15 | 162 | 11 | 17 | 0 |
30 Sep 15 | 157 | 8 | 17 | 0 |
30 Jun 15 | 151 | 5 | 16 | 0 |
30 Jun 14 | 4 | 3 | 1 | 0 |
양질의 수익: IDX 은(는) 현재 수익성이 없습니다.
이익 마진 증가: IDX 은(는) 현재 수익성이 없습니다.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: IDX 은(는) 수익성이 없으며 지난 5년 동안 연간 24.6% 비율로 손실이 증가했습니다.
성장 가속화: 현재 수익성이 없기 때문에 IDX 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.
수익 대 산업: IDX 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( -19.1% )와 비교하기 어렵습니다.
자기자본 수익률
높은 ROE: IDX 현재 수익성이 없기 때문에 마이너스 자본 수익률( -19.26% )을 갖습니다.